My friend @robertferrismdphd.bsky.social from @UPMC @UNC was a formidable opponent in this #Bridge2024 debate !

Thank you @PAscierto and #IgorPuzanov for the invite to @ComuneNapoli @istitutotumori

Dr. Lesinski @lesinskilab.bsky.social and I are excited to attend Immunotherapy Bridge Meeting in Napoli #Bridge2024 and learn from colleagues @bernardafox.bsky.social @patrickhwumd.bsky.social @winshipatemory.bsky.social @sitcancer.bsky.social #PAscierto

WORK HARD, PLAY HARD! Celebrate your success & commiserate over failures / #Immunotherapy #Bridge2024 is over & the 15th #Melanoma Bridge has started. Great being in #Napoli with so many friends. PAscierto, Choueiri, Hamid, Tawbi @samirkhleif.bsky.social , Bruno, Guerrero, @sitcancer.bsky.social

Prof Paolo Ascierto #Melanoma #Immunotherapy ROCKSTAR Istituto Nazionale IRCCS Fondazione “G Pascale” talks about salvage therapy post 1st line failure #Bridge2024 @sitcancer.bsky.social @PAscierto

IT HAS STARTED! The 10th #Immunotherapy #Bridge2024 Prof. @PAscierto opens conf with a quick review of decade worth of meetings. Even thru #SarsCov2 this meeting never skipped a beat. Looking forward to 4 days of excellent talks & debates. @sitcancer.bsky.social #cancer #FinishCancer #NCI

💥It has started! Day 2 of #melanoma #Bridge2024 Drs. Blank @nkinl.bsky.social Postow @mskcancercenter.bsky.social Osman @csmapnyu.org Ernstoff @ #NCI Levesque #Vivenko @pascierto

1) Prof #PAscierto provides an overview of the #BestOf #SITC2024 /Lots of great science / Starts with remembering Prof Jeffery S. Weber MD PHD whom we lost too soon to #pancreaticCancer @sitcancer.bsky.social #NYU #LangoneCancerCenter

Discussion of Prof Mitch Levesque data / Amazing single cell #melanoma phenotypes/ can it explain resistance? Thinks metabolic signature? Functional data more important
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto

2) Prof #PAscierto provides an overview of the #BestOf #SITC2024 /Lots of great science /appears patients who respond to #CPI have signatures of #anticancer #immunity in pretreatment and on treatment biopsies @sitcancer.bsky.social #ucla #SWOG #PICI #Agillent #ionPath @melanomaau.bsky.social

4) 1) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma understanding failure of small molecules / #targeted #therapy/ new tu phenotypes/ sc mel phenotypes/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto

3) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto

2) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto

1) Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/
#Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto